Indoco Remedies Ltd

About the Company :

Indoco Remedies is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in India. Indoco has a strong international presence in the Regulated and Emerging markets.

Indoco today, has a well-built brand portfolio of 135 products in various therapeutic segments, including high growth life style segments such as Anti-Diabetics, Cardiovascular, Central Nervous System, Musculo-Skeletal, Nutrition and Dental care. In March 2016, the company has received USFDA approval for its solid dosages plant I in Goa. This plant has a capacity to manufacture 2.2 billion tablets, 32 million bottles of liquid orals, 16 million tubes of creams and ointments and 60 million capsules of hard gelatin. The plant has capability to manufacture aqueous, non-aqueous and photosensitive products. It has HVAC system that maintains relative humidity to 40 per cent +/- five per cent. Apart from approval from US FDA, this plant is also approved by UK-MHRA, MCC-South Africa, TGA-Australia and ANVISA-Brazil.

Indoco Remedies gets USFDA approval for febuxostat

Indoco Remedies has received final USFDA approval for febuxostat tablets 40 mg and 80 mg from US Food and Drug ...

Read More

Indoco Remedies receives USFDA approval for Rasagiline tablets

Indoco Remedies on has received USFDA approval for Rasagiline tablets which are used for the treatment of Parkinson’s disease. The ...

Read More

Indoco Remedies plans expansion programme

Indoco Remedies is planning an expansion programme at its sterile ophthalmic manufacturing facility in Goa with an investment of Rs ...

Read More

Other Office Address

t